Mizuho Securities Starts Xencor, Inc. (XNCR) at Buy

https://www.streetinsider.com/Analyst+Comments/Mizuho+Securities+Starts+Xencor%2C+Inc.+%28XNCR%29+at+Buy/15605831.html

Mizuho Securities Starts Fate Therapeutics (FATE) at Buy

Target $27

https://www.streetinsider.com/Analyst+Comments/Mizuho+Securities+Starts+Fate+Therapeutics+%28FATE%29+at+Buy/15605838.html

Mizuho Securities Starts CytomX Therapeutics (CTMX) at Buy

https://www.streetinsider.com/Analyst+Comments/Mizuho+Securities+Starts+CytomX+Therapeutics+%28CTMX%29+at+Buy/15605861.html

Medidata cut to Neutral from Buy by Guggenheim

Target $92.25

https://www.benzinga.com/stock/MDSO/ratings

Misonix started at Buy by BTIG

https://www.benzinga.com/stock/MSON/ratings

CymaBay upped to Strong Buy from Outperform by Raymond James

https://www.benzinga.com/stock/CBAY/ratings

Quorum Health discontinues hospital operations in Illinois

Quorum Health (NYSE:QHC) announces that MetroSouth Medical Center in Blue Island, Illinois filed an application to discontinue hospital operations.

If the Company is not able to divest the facility, it will discontinue all operations by the end Q4.

This decision is a result of mounting financial losses due to decreasing patient volumes, increasing market saturation, and reduced reimbursement from government and commercial payors.

https://seekingalpha.com/news/3470675-quorum-health-discontinues-hospital-operations-illinois